EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

IGFBP6 orchestrates antiinfective immune collapse in murine sepsis via prohibitin-2–mediated immunosuppression

Kai Chen, Ying Hu, Xiaoyan Yu, Hong Tang, Yanting Ruan, Yue Li, Xun Gao, Qing Zhao, Hong Wang, Xuemei Zhang, David Paul Molloy, Yibing Yin und 2 weitere

Journal of Clinical Investigation · 03.11.2025 · 135 (21)

DOI: 10.1172/jci184721 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Clinical Investigation, online erschienen am 02.09.2025. Verfasst von Kai Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disord…. Hauptthemen laut MEDLINE: Sepsis, Repressor Proteins, Insulin-Like Growth Factor Binding Proteins, Immune Tolerance. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chongqing Science and Technology Bureau, Chongqing, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The persistent challenge of sepsis-related mortality underscores the necessity for deeper insights. Our multicenter, cross-age cohort study identified insulin-like growth factor binding protein 6 (IGFBP6) as a critical regulator in sepsis diagnosis, prognosis, and mortality risk evaluation. Mechanistically, IGFBP6 engages in IGF-independent binding to prohibitin2 (PHB2) on epithelial cells, driving PHB2 tyrosine phosphorylation during sepsis. This process disrupts STAT1 phosphorylation, nuclear translocation, and its recruitment to the CCL2 promoter, ultimately impairing CCL2 transcription and macrophage chemotaxis. Crucially, PHB2 silencing via siPHB2 and STAT1 activation using 2-NP restored CCL2 expression in vitro and in vivo, improving bacterial clearance and survival in septic mice. Concurrently, IGFBP6 compromised macrophage bactericidal activity by inhibiting Akt phosphorylation, reducing ROS/IL-1β production and phagocytic capacity — defects reversible by Akt agonist SC79. Collectively, IGFBP6 emerges as an endogenous driver of sepsis pathogenesis, positioning it as a dual diagnostic biomarker and therapeutic target. Intervention strategies targeting IGFBP6-mediated signaling may offer transformative approaches for sepsis management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SepsisRepressor ProteinsInsulin-Like Growth Factor Binding ProteinsImmune ToleranceAnimalsMiceProhibitinsHumansMacrophagesMaleFemaleSignal TransductionIntercellular Signaling Peptides and ProteinsGrowth Arrest-Specific Protein 6

Stichwörter der Autor:innen

ImmunotherapyInfectious diseaseInflammationMacrophages

Substanzen

ProhibitinsRepressor ProteinsInsulin-Like Growth Factor Binding ProteinsIntercellular Signaling Peptides and ProteinsGrowth Arrest-Specific Protein 6Phb2 protein, mousePHB2 protein, human

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Dis…
  • Department of Laboratory Medicine, Key Laboratory of Diagnostic Medicine, Chongqing Medical University, Chongqing, China.
  • Department of Critical Care Medicine, Department of Surgical Intensive Care Unit, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Molecular Medicine and Cancer Research Center, College of Basic Medical Sciences, Chongqing Medical University, Chongqing, China.
  • Center of Clinical Laboratory Medicine, Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China.
  • Department of Laboratory Medicine, the Second Affiliated Hospital of Chongqing Medical, University, Chongqing, China.

Förderung

  • Chongqing Science and Technology Bureau, Chongqing, China

Zitieren

APA

Chen, K., Hu, Y., Yu, X., Tang, H., Ruan, Y., Li, Y., Gao, X., Zhao, Q., Wang, H., Zhang, X., Molloy, D. P., Yin, Y., Chen, D., & Song, Z. (2025). IGFBP6 orchestrates antiinfective immune collapse in murine sepsis via prohibitin-2–mediated immunosuppression. Journal of Clinical Investigation, 135(21). https://doi.org/10.1172/jci184721

Vancouver

Chen K, Hu Y, Yu X, Tang H, Ruan Y, Li Y, et al. IGFBP6 orchestrates antiinfective immune collapse in murine sepsis via prohibitin-2–mediated immunosuppression. Journal of Clinical Investigation. 2025;135(21). doi:10.1172/jci184721

BibTeX
@article{Chen2025,
  author = {Chen, Kai and Hu, Ying and Yu, Xiaoyan and Tang, Hong and Ruan, Yanting and Li, Yue and Gao, Xun and Zhao, Qing and Wang, Hong and Zhang, Xuemei and Molloy, David Paul and Yin, Yibing and Chen, Dapeng and Song, Zhixin},
  title = {IGFBP6 orchestrates antiinfective immune collapse in murine sepsis via prohibitin-2–mediated immunosuppression},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  volume = {135},
  number = {21},
  doi = {10.1172/jci184721}
}
Kostenlos starten →